The estimated Net Worth of Patrick John Finn is at least $15 Milione dollars as of 5 August 2024. Mr. Finn owns over 2,885 units of Twist Bioscience Corp stock worth over $7,466,986 and over the last 6 years he sold TWST stock worth over $4,542,054. In addition, he makes $3,013,680 as Chief Commercial Officer at Twist Bioscience Corp.
Patrick has made over 45 trades of the Twist Bioscience Corp stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 2,885 units of TWST stock worth $115,198 on 5 August 2024.
The largest trade he's ever made was selling 37,000 units of Twist Bioscience Corp stock on 25 September 2019 worth over $940,910. On average, Patrick trades about 3,634 units every 18 days since 2018. As of 5 August 2024 he still owns at least 168,327 units of Twist Bioscience Corp stock.
You can see the complete history of Mr. Finn stock trades at the bottom of the page.
Patrick John Finn Ph.D. serves as Chief Commercial Officer of the Company. He as our Senior Vice President of Commercial Operations from December 2018 to October 2019. Prior to joining us, Dr. Finn was Vice President of Sales at Enzymatics Inc., a developer, manufacturer, and marketer of enzymes for molecular biology applications, sold predominantly to manufacturers in research and diagnostic markets from January 2012 to March 2015. Dr. Finn holds a B.Sc. in Chemistry from Heriot-Watt University and a Ph.D. in Chemistry from the University of Southampton.
As the Chief Commercial Officer of Twist Bioscience Corp, the total compensation of Patrick Finn at Twist Bioscience Corp is $3,013,680. There are 2 executives at Twist Bioscience Corp getting paid more, with Emily Leproust having the highest compensation of $8,126,160.
Patrick Finn is 48, he's been the Chief Commercial Officer of Twist Bioscience Corp since 2019. There are 20 older and 2 younger executives at Twist Bioscience Corp. The oldest executive at Twist Bioscience Corp is Dr. William Charles Banyai Ph.D., 66, who is the Sr. VP of Advanced Devel., GM of Data Storage & Director.
Patrick's mailing address filed with the SEC is C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080.
Over the last 6 years, insiders at Twist Bioscience Corp have traded over $141,837,821 worth of Twist Bioscience Corp stock and bought 168,550 units worth $2,482,088 . The most active insiders traders include Fred B Craves, Keith Crandell e Emily M. Leproust. On average, Twist Bioscience Corp executives and independent directors trade stock every 8 days with the average trade being worth of $465,824. The most recent stock trade was executed by Dennis Cho on 6 September 2024, trading 275 units of TWST stock currently worth $10,769.
at twist bioscience, our expertise is synthetic dna. we have developed a proprietary semiconductor-based synthetic dna manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, such as oligonucleotides, genes, pathways, chassis and genomes. by synthesizing dna on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic dna production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production. the twist bioscience platform has the potential to greatly accelerate the development of personalized medicine, sustainable chemical production, improved agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. for more information, please visit www.twistbioscience.com .
Twist Bioscience Corp executives and other stock owners filed with the SEC include: